Ardelyx ARDX Business Segments — Stock-Based Comp
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's business segments — stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's business segments — stock-based comp?
- Ardelyx (ARDX) reported business segments — stock-based comp of $14.16M in Q1 2026.
- How has Ardelyx's business segments — stock-based comp changed year-over-year?
- Ardelyx's business segments — stock-based comp increased by 17.1% year-over-year, from $12.09M to $14.16M.
- What is the long-term trend for Ardelyx's business segments — stock-based comp?
- Over 3 years (2022 to 2025), Ardelyx's business segments — stock-based comp has grown at a 24.9% compound annual growth rate (CAGR), from $25.14M to $48.96M.
- What does business segments — stock-based comp mean?
- Represents the non-cash expense associated with equity-based awards granted to employees and executives as part of their total compensation. This metric reflects the cost of talent retention and alignment of interests between staff and shareholders. It is a significant component of operating expenses for growth-stage biotechnology firms.